Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rethinking the economics and flexibility of U.S. nuclear power through hydrogen integration and policy support.

Nature communications·2026
Same author

Digital vs conventional glycemic monitoring in rare endocrine cancers: comparison of effectiveness during chemotherapy.

Endocrine connections·2026
Same author

Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTC.

Endocrine-related cancer·2026
Same author

Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia.

Diabetes, obesity & metabolism·2025
Same author

Real-world efficacy and safety of selpercatinib in RET-mutant medullary thyroid cancer at a Tertiary Referral Center.

European journal of endocrinology·2025
Same author

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

The Journal of clinical endocrinology and metabolism·2025

相关实验视频

Updated: Jul 12, 2025

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.1K

赫丁格综合症 - - 学到的经验:一个单一中心的经验.

Mohamed El Gabry1, Sven Arends2, Sharaf-Eldin Shehada1

  • 1Department of Thoracic and Cardiovascular Surgery, West-German Heart and Vascular Centre, 45147 Essen, Germany.

Journal of cardiovascular development and disease
|October 27, 2023
PubMed
概括

通过手术治疗黑丁格综合征 (HS),这是神经内分泌瘤 (NETs) 的罕见心脏并发症,可以延长存活时间. 谨慎的患者选择对于这种高风险的心脏手术至关重要.

关键词:
赫丁格综合征是什么意思 赫丁格综合征是什么意思癌性心脏病 (CD) 是一种心脏病.血 perfusion 输血 输血 输血 输血 输血神经内分泌瘤 (NET) 是一种八重胺的使用方法三管门的三管门

更多相关视频

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
08:51

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

4.1K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.5K

相关实验视频

Last Updated: Jul 12, 2025

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.1K
Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model
08:51

Author Spotlight: Hickman Catheter Use for Long-Term Vascular Access in a Preclinical Swine Model

Published on: March 31, 2023

4.1K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.5K

科学领域:

  • 心脏病学 心脏病学
  • 心脏外科手术 心脏外科手术
  • 在瘤学瘤学.

背景情况:

  • 赫丁格综合征 (HS),也称为癌性心脏病 (CD),是神经内分泌瘤 (NETs) 的罕见但严重的并发症.
  • 脊髓炎显著影响心脏功能,特别是三门和右心室.
  • 对于晚期HS患者来说,外科干预通常是必要的.

研究的目的:

  • 报告赫丁格综合征患者的手术策略和中期结果.
  • 评估HS的不同手术方法的可行性和安全性.
  • 确定影响心脏手术的HS患者生存的因素.

主要方法:

  • 对2005年至2023年期间接受心脏手术的11名HS患者的回顾性分析.
  • 详细审查手术程序,包括三巴置换,重建和新型植入技术 (TVI).
  • 对并发手术的评估,对右心室衰竭的管理 (例如,ECMO,血液输血) 和患者的治疗结果.

主要成果:

  • 所有患者呈现出严重症状 (NYHA III-IV 类) 和三管卷入.
  • 外科干预包括三巴置换 (4),重建 (3) 和三巴植入 (4).
  • 30天死亡率为18%,随访时间中位数为2年,随访期间总死亡率为72.7%.

结论:

  • 对HS的心脏手术是一种高风险但可能延长生命的手术.
  • 手术策略的选择和患者的选择对于成功的结果至关重要.
  • 为了优化HS管理,需要对更大的队列进行进一步的研究和扩大后续监测.